Literature DB >> 2766418

Application of dibutyltin oxide method to regioselective acylation and alkylation of tylosin at C-4''.

K Kiyoshima, M Sakamoto, T Ishikura, Y Fukagawa, T Yoshioka, H Naganawa, T Sawa, T Takeuchi.   

Abstract

4''-O-Acyl-, 4''-O-alkyl- and 4''-deoxy-tylosin derivatives were synthesized using 2'-O-acetyl-3'',4''-O-(dibutyl-stannio)tylosin as a synthetic intermediate. The in vitro biological evaluation showed that the new derivatives were active against macrolide-resistant clinical isolates of bacteria and mycoplasmas, and that they were resistant to hepatic esterase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766418     DOI: 10.1248/cpb.37.861

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  In vitro activity of YM133, a new semisynthesized macrolide.

Authors:  T Terasawa; M Watanabe; T Okubo; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.

Authors:  Thomas W von Geldern; Howard E Morton; Rick F Clark; Brian S Brown; Kelly L Johnston; Louise Ford; Sabine Specht; Robert A Carr; Deanne F Stolarik; Junli Ma; Matthew J Rieser; Dominique Struever; Stefan J Frohberger; Marianne Koschel; Alexandra Ehrens; Joseph D Turner; Marc P Hübner; Achim Hoerauf; Mark J Taylor; Stephen A Ward; Kennan Marsh; Dale J Kempf
Journal:  PLoS Negl Trop Dis       Date:  2019-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.